argenx SE Revenue

In the year 2024, argenx SE had annual revenue of $2.25B with 77.22% growth. argenx SE had revenue of $757.39M in the quarter ending December 31, 2024, with 81.26% growth.

Revenue

2.25B

Revenue Growth

+77.22%

P/S Ratio

n/a

Revenue / Employee

1.41M

Employees

1,599

Market Cap

35.64B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.25B	979.61M	77.22%
Dec 31, 2023	1.27B	827.58M	187.66%
Dec 31, 2022	441.01M	-87.25M	-16.52%
Dec 31, 2021	528.27M	466.31M	752.59%
Dec 31, 2020	61.96M	-30.85M	-33.24%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Endo Inc.	1.76B
SS Innovations International	16.04M
Veradigm	588.02M
Elite Pharmaceuticals	70.00M
Glass House Brands	200.90M
Northwest Biotherapeutics	1.60M
Silence Therapeutics	43.26M
American Oncology Network	1.76B

Revenue Rankings

argenx SE News

5 days ago - Looking Into argenx's Recent Short Interest - Benzinga
7 days ago - Argenx: The Magic May Be Already Priced In - Seeking Alpha
11 days ago - P/E Ratio Insights for argenx - Benzinga
24 days ago - argenx SE (ARGX) Announces Promising Data for VYVGART at AAN Annual Meeting - GuruFocus
24 days ago - argenx Highlights FcRn Leadership with Long-term Data and Transformational Patient Outcomes at the American Academy of Neurology 2025 Annual Meeting - GlobeNewsWire
4 weeks ago - argenx targets 12,000 CIDP patients with VYVGART expansion in 2025 - Seeking Alpha
4 weeks ago - argenx SE (ARGX) Q4 2024 Earnings Call Transcript - Seeking Alpha
4 weeks ago - argenx: Vyvgart's Sales Momentum Improves, Clinical Data Updates From A Key Competitor Imminent - Seeking Alpha

More News